Association of programmed death ligand 1 expression with prognosis among patients with ten uncommon advanced cancers

Torben Steiniche; Morten Ladekarl; Jeanette Bæhr Georgsen; Simon Andreasen; Michael Busch-Sørensen; Wei Zhou; Matthew J Marton; Scott K Pruitt; Fan Jin; Kai-Li Liaw

doi:10.2144/fsoa-2020-0063

Association of programmed death ligand 1 expression with prognosis among patients with ten uncommon advanced cancers

Torben Steiniche, Morten Ladekarl, Jeanette Bæhr Georgsen, Simon Andreasen, Michael Busch-Sørensen, Wei Zhou, Matthew J Marton, Scott K Pruitt, Fan Jin, Kai-Li Liaw

Øre-, Næse-, Hals- og Kæbekirurgisk Afdeling

Publikation: Bidrag til tidsskrift › Artikel › Forskning › peer review

Abstrakt

Aim: PD-L1 expression and high levels of microsatellite instability (MSI-H) may predict response to checkpoint inhibitors, but their prevalence and prognostic value are unknown in many cancers.

Methods: We retrospectively evaluated PD-L1 combined positive score (CPS) and MSI-H and their association with clinical outcomes among patients with ten advanced uncommon cancers.

Results: 398 of 426 patients (93%) had a valid PD-L1 result; most (242; 61%) had CPS ≥1. Prevalence of MSI-H tumors was 8/360. Median overall survival was shorter among patients with PD-L1 CPS ≥1 tumors after first-line treatment (23.0 vs 39.7 months, p = 0.014).

Conclusion: PD-L1 was commonly expressed in solid tumors, and CPS ≥1 was associated with shorter overall survival. Prevalence of MSI-H was low.

Originalsprog	Engelsk
Artikelnummer	FSO616
Tidsskrift	Future Science OA
Vol/bind	6
Udgave nummer	8
DOI	https://doi.org/10.2144/fsoa-2020-0063
Status	Udgivet - 19 aug. 2020

Bibliografisk note

Adgang til dokumentet

10.2144/fsoa-2020-0063Licens: CC BY

Citationsformater

@article{cb1838dc6609459d889755542cc5f4d6,

title = "Association of programmed death ligand 1 expression with prognosis among patients with ten uncommon advanced cancers",

abstract = "Aim: PD-L1 expression and high levels of microsatellite instability (MSI-H) may predict response to checkpoint inhibitors, but their prevalence and prognostic value are unknown in many cancers.Methods: We retrospectively evaluated PD-L1 combined positive score (CPS) and MSI-H and their association with clinical outcomes among patients with ten advanced uncommon cancers.Results: 398 of 426 patients (93%) had a valid PD-L1 result; most (242; 61%) had CPS ≥1. Prevalence of MSI-H tumors was 8/360. Median overall survival was shorter among patients with PD-L1 CPS ≥1 tumors after first-line treatment (23.0 vs 39.7 months, p = 0.014).Conclusion: PD-L1 was commonly expressed in solid tumors, and CPS ≥1 was associated with shorter overall survival. Prevalence of MSI-H was low.",

author = "Torben Steiniche and Morten Ladekarl and Georgsen, {Jeanette B{\ae}hr} and Simon Andreasen and Michael Busch-S{\o}rensen and Wei Zhou and Marton, {Matthew J} and Pruitt, {Scott K} and Fan Jin and Kai-Li Liaw",

note = "{\textcopyright} 2020 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA.",

year = "2020",

month = aug,

day = "19",

doi = "10.2144/fsoa-2020-0063",

language = "English",

volume = "6",

journal = "Future Science OA",

issn = "2056-5623",

publisher = "Future Medicine Ltd.",

number = "8",

}

Association of programmed death ligand 1 expression with prognosis among patients with ten uncommon advanced cancers. / Steiniche, Torben; Ladekarl, Morten; Georgsen, Jeanette Bæhr; Andreasen, Simon; Busch-Sørensen, Michael; Zhou, Wei; Marton, Matthew J; Pruitt, Scott K; Jin, Fan; Liaw, Kai-Li.

I: Future Science OA, Bind 6, Nr. 8, FSO616, 19.08.2020.

Publikation: Bidrag til tidsskrift › Artikel › Forskning › peer review

TY - JOUR

T1 - Association of programmed death ligand 1 expression with prognosis among patients with ten uncommon advanced cancers

AU - Steiniche, Torben

AU - Ladekarl, Morten

AU - Georgsen, Jeanette Bæhr

AU - Andreasen, Simon

AU - Busch-Sørensen, Michael

AU - Zhou, Wei

AU - Marton, Matthew J

AU - Pruitt, Scott K

AU - Jin, Fan

AU - Liaw, Kai-Li

PY - 2020/8/19

Y1 - 2020/8/19

N2 - Aim: PD-L1 expression and high levels of microsatellite instability (MSI-H) may predict response to checkpoint inhibitors, but their prevalence and prognostic value are unknown in many cancers.Methods: We retrospectively evaluated PD-L1 combined positive score (CPS) and MSI-H and their association with clinical outcomes among patients with ten advanced uncommon cancers.Results: 398 of 426 patients (93%) had a valid PD-L1 result; most (242; 61%) had CPS ≥1. Prevalence of MSI-H tumors was 8/360. Median overall survival was shorter among patients with PD-L1 CPS ≥1 tumors after first-line treatment (23.0 vs 39.7 months, p = 0.014).Conclusion: PD-L1 was commonly expressed in solid tumors, and CPS ≥1 was associated with shorter overall survival. Prevalence of MSI-H was low.

AB - Aim: PD-L1 expression and high levels of microsatellite instability (MSI-H) may predict response to checkpoint inhibitors, but their prevalence and prognostic value are unknown in many cancers.Methods: We retrospectively evaluated PD-L1 combined positive score (CPS) and MSI-H and their association with clinical outcomes among patients with ten advanced uncommon cancers.Results: 398 of 426 patients (93%) had a valid PD-L1 result; most (242; 61%) had CPS ≥1. Prevalence of MSI-H tumors was 8/360. Median overall survival was shorter among patients with PD-L1 CPS ≥1 tumors after first-line treatment (23.0 vs 39.7 months, p = 0.014).Conclusion: PD-L1 was commonly expressed in solid tumors, and CPS ≥1 was associated with shorter overall survival. Prevalence of MSI-H was low.

U2 - 10.2144/fsoa-2020-0063

DO - 10.2144/fsoa-2020-0063

M3 - Article

C2 - 32983568

VL - 6

JO - Future Science OA

JF - Future Science OA

SN - 2056-5623

IS - 8

M1 - FSO616

ER -

Association of programmed death ligand 1 expression with prognosis among patients with ten uncommon advanced cancers

Abstrakt

Bibliografisk note

Adgang til dokumentet

Fingeraftryk

Citationsformater